Premium
China’s Shanghai Fosun Pharmaceutical Group, which acquired a majority stake in Gland Pharma Ltd less than three years ago, will sell about a fifth of its stake in the drugmaker through its proposed initial public offering. Gland Pharma has filed its draft prospectus with the Securities and Exchange Board of India ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
